Compared to the septic shock group, COVID-19 patients exhibited a distinct coagulopathy profile, characterized by significantly higher levels of sEVs-associated TF and enhanced EVs-mediated fibrinolytic activity. The gene discussed is TF; the disease is COVID-19.